SIGNIFY HEALTH INC -CLASS A (SGFY) Stock Fundamental Analysis
USA - NYSE:SGFY - US82671G1004 - Common Stock
30.49 USD
+0.02 (+0.07%)
30.49 USD
0 (0%)
SGFY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. The financial health of SGFY is average, but there are quite some concerns on its profitability. SGFY is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SGFY had negative earnings in the past year.
SGFY had a positive operating cash flow in the past year.
In the past 5 years SGFY reported 4 times negative net income.
SGFY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SGFY has negative profitability rations, so we won't be analyzing them here.
With a decent Return On Invested Capital value of 6.14%, SGFY is doing good in the industry, outperforming 67.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 6.14% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SGFY has a better Operating Margin (13.53%) than 89.38% of its industry peers.
In the last couple of years the Operating Margin of SGFY has grown nicely.
SGFY's Gross Margin of 45.33% is fine compared to the rest of the industry. SGFY outperforms 72.57% of its industry peers.
In the last couple of years the Gross Margin of SGFY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% |
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SGFY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SGFY has more shares outstanding
The debt/assets ratio for SGFY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.36 indicates that SGFY is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.36, SGFY is in the better half of the industry, outperforming 76.99% of the companies in the same industry.
SGFY has a debt to FCF ratio of 93.50. This is a negative value and a sign of low solvency as SGFY would need 93.50 years to pay back of all of its debts.
The Debt to FCF ratio of SGFY (93.50) is comparable to the rest of the industry.
SGFY has a Debt/Equity ratio of 0.53. This is a neutral value indicating SGFY is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, SGFY is in the better half of the industry, outperforming 60.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Altman-Z | 3.36 |
ROIC/WACC0.66
WACC9.37%
2.3 Liquidity
A Current Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
SGFY's Current ratio of 1.62 is fine compared to the rest of the industry. SGFY outperforms 67.26% of its industry peers.
SGFY has a Quick Ratio of 1.62. This is a normal value and indicates that SGFY is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SGFY (1.62) is better than 72.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
SGFY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -390.91%.
The Revenue has grown by 23.33% in the past year. This is a very strong growth!
SGFY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.09% yearly.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
3.2 Future
SGFY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 93.52% yearly.
The Revenue is expected to grow by 18.33% on average over the next years. This is quite good.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 94.60 indicates a quite expensive valuation of SGFY.
The rest of the industry has a similar Price/Forward Earnings ratio as SGFY.
When comparing the Price/Forward Earnings ratio of SGFY to the average of the S&P500 Index (22.55), we can say SGFY is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 |
4.2 Price Multiples
SGFY's Enterprise Value to EBITDA ratio is in line with the industry average.
SGFY's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1516.44 | ||
| EV/EBITDA | 32.74 |
4.3 Compensation for Growth
SGFY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SGFY's earnings are expected to grow with 93.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SGFY has a Yearly Dividend Yield of 1.26%.
SGFY's Dividend Yield is rather good when compared to the industry average which is at 2.49. SGFY pays more dividend than 85.84% of the companies in the same industry.
With a Dividend Yield of 1.26, SGFY pays less dividend than the S&P500 average, which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
5.2 History
SGFY is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
30.49
+0.02 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.46%
Ins Owner Change0%
Market Cap5.46B
Revenue(TTM)805.50M
Net Income(TTM)-576800000
Analysts70
Price Target30.01 (-1.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-788.65%
Min EPS beat(2)-1114.2%
Max EPS beat(2)-463.11%
EPS beat(4)1
Avg EPS beat(4)-261.16%
Min EPS beat(4)-1114.2%
Max EPS beat(4)761.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.89%
Min Revenue beat(2)-42.43%
Max Revenue beat(2)-11.35%
Revenue beat(4)0
Avg Revenue beat(4)-14.07%
Min Revenue beat(4)-42.43%
Max Revenue beat(4)-0.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 | ||
| P/S | 6.78 | ||
| P/FCF | 1516.44 | ||
| P/OCF | 171.13 | ||
| P/B | 8.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.74 |
EPS(TTM)-0.32
EYN/A
EPS(NY)0.32
Fwd EY1.06%
FCF(TTM)0.02
FCFY0.07%
OCF(TTM)0.18
OCFY0.58%
SpS4.5
BVpS3.5
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 6.14% | ||
| ROICexc | 9.77% | ||
| ROICexgc | N/A | ||
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)5.48%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y104.84%
ROICexc growth 5YN/A
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Debt/EBITDA | 2.07 | ||
| Cap/Depr | 52.6% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z | 3.36 |
F-Score3
WACC9.37%
ROIC/WACC0.66
Cap/Depr(3y)53.08%
Cap/Depr(5y)45.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
EBIT growth 1Y26.74%
EBIT growth 3Y75.98%
EBIT growth 5YN/A
EBIT Next Year153.12%
EBIT Next 3Y41%
EBIT Next 5Y25.5%
FCF growth 1Y-96.67%
FCF growth 3Y-39.43%
FCF growth 5YN/A
OCF growth 1Y-75.44%
OCF growth 3Y-8.54%
OCF growth 5YN/A
SIGNIFY HEALTH INC -CLASS A / SGFY FAQ
Can you provide the ChartMill fundamental rating for SIGNIFY HEALTH INC -CLASS A?
ChartMill assigns a fundamental rating of 4 / 10 to SGFY.
What is the valuation status for SGFY stock?
ChartMill assigns a valuation rating of 3 / 10 to SIGNIFY HEALTH INC -CLASS A (SGFY). This can be considered as Overvalued.
What is the profitability of SGFY stock?
SIGNIFY HEALTH INC -CLASS A (SGFY) has a profitability rating of 1 / 10.
What is the financial health of SIGNIFY HEALTH INC -CLASS A (SGFY) stock?
The financial health rating of SIGNIFY HEALTH INC -CLASS A (SGFY) is 6 / 10.